A randomized double-blind study was conducted to compare the radiographic quality and adverse reactions in myelography of the two non ionic water-soluble contrast media , iopamidol and metrizamide. A total of 46 myelograms were obtained, 28 with iopamidol and 18 with metrizamide. Untoward reactions consisted of nausea, headaches, back and leg pain, neuropsychiatric findings , and urinary retention. lopamidol caused no reactions in 20 of the 28 cases, while metrizamide caused no reactions in only three of 18 cases. Film quality evaluation showed 22 of the 28 studies with iopamidol were judged excellent, whereas only 11 of the 18 metrizamide studies were judged excellent. The results of this study suggest that iopamidol produces better quality studies with fewer and milder adverse reactions than metrizamide.
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Thi s randomized double-blind study was conducted to compare th e radiographic quality and adverse reactions of the two non ionic water-solubl e contrast media, iopamidol and metrizamide, in myelography. Th e use of water-soluble contrast media for myelography was proposed by Alm en [1] in 1969. The first non ionic medium introduced for clinic al use was metrizamide. Metrizamide was found to give better visu alization of nerve roots and sleeves than Pantopaque [2] and also showed low neurotoxicity [3] . Clinical use of metrizamide has not revealed serious, permanent reactions to the drug, although seizures and acute mental changes have been found [4] [5] [6] .
A new water-solubl e contrast agent, iopamidol, has been introduced for myelography. lopamidol was initially formulated by Bracco Industria Chemica of Milan , Italy, and is currently being developed by th e Squibb Institute. Th e development and physicochemi ca l properties of iopamidol have been reported by Pitre and Felder [7] , and several papers on the clinical use of iopamidol have been published [8] [9] [10] . We report our findings when iopamidol and metriza mid e were compared for adverse reactions and radiographic quality.
Materials and Methods
In thi s study 46 myelograms were obtained, 28 with iopamidol and 18 with metrizamide. Patient selection was entirely at random . All male pati ents and nonpregnant females over 18 years of age who required lumbar myelography, thoracic myelography, cervical mye lograph y, total c olumn ar myelography , CT cisternography , or CT ventriculography were asked to participate. Every patient was fully informed of the experimental nature of iopamidol. Reason s for exclusion from the study included: pregnancy; planned surgery within 24 hrs; hypersensitivity to iodine compounds; spinal pun cture within the past month; bloody cerebrospinal fluid; increased intracranial pressure or suspicion of intracranial tumor; abscess or hematoma; medication with agents that lower the seizure threshol.j ; or a history of convulsive disorders, multiple sclerosis, psyc hosis. alcoholism , or drug abuse .
Each patient selected had a complete medical history taken within 5 days before the study, and underwent a thorough physical and neurologic examination before and after the myelogram . A nurse obtained vital signs before drug administration and at 15 min, 3 0 min, and 1, 4, 8, 24, and 72 hr after administration. Th e nurse interviewed each patient within 6 hr after the procedure and at 24, 48, and 72 hr postmyelography, noting any adverse reactions. A complete laboratory profile was also taken on each patient before and after myelography.
In this study , all myelograms were obtained by lumbar punct ure. Each patient was randomly assigned either metrizamide or ioparn idol, and the contrast medium used was unknown to the neuroradiologist performing the study. Each patient was premedicated with 120 mg intramuscular phenobarbital, and 15 ml of contrast medium was used in every case, except for one ventriculogram in wh ich 5 ml was used . The concentration was the same for each mediu m for each region of the spine examined . In the thoracic and lu mbar regions 200 mg / dl iodine was used , and in the cervic al area 300 mg / dl iodine was used . Patients were put in a head-up su pine position for at least the first 8 hr after the procedure and then in a horizontal position for another 1 6 hours.
In addition to studying the adverse reactions produced by e :~c h contrast medium , the radiographic quality of each study was evaluated by two experienced neuroradiologists who were unaware of the medium used . Particular attention was paid to contrast density discrimination and how well the nerve roots and sleeves W0re visualized . Studies were graded as excellent, good , fair , or pocr.
Results
Untoward reactions consisted of nausea, headaches, bac k ,lnd leg pain, neuropsychiatric findings, and retention of urine. The neuropsychiatric findings included dizziness , confusion, anc l or hallucinations. No seizures occurred with either contrast med ium. Table 1 lists the incidence of adverse reactions , and summ ar,zes th e overall results of untoward reactions for each drug. It should be noted that patients given iopamidol did complain of nausea 1nd Note .-Chi-squ are test showed th e grouped da ta to be significantl y different al th e p = 0. 05-0.1 level.
• Three stu dies e xc luded fo r reasons not releva nt to the compari son.
headaches but did not complain of pain, neuropsyc hi atri c findings , or retenti on of urine. Th e chi-squ are test sh owed the se data to be significantly different at th e p < 0 .001 level.
In addition to studying adverse reaction s, th e rad iographi c quality of each study was also judged . Table 2 summarizes th e results of those findings . Three iopamidol studi es were eliminated from th e quality evalu ation for radi og raphi c technica l reasons. Th e c hisquare test showed th e g rouped data to be significantl y different at the p = 0 .05 to p = 0 .1 level.
Discussion
Headac hes were th e most frequent adverse reacti on. Seven of the 28 patients given iopam idol co mplained of headaches , as did nine of the 18 patients g iven metrizamide. Thi s fin d in g is in ag reement with a prior report [8] li sting headache as th e most freq uent side effect wh en th e use of iopamidol and metrizami de in mye lography was compared . The severity of the headaches also differed accord ing to whic h contrast medium was used. Each headache was classified as mild , moderate, or seve re. Four of th e seven headac hes of pati ents usi ng iopam idol were judged to be mild, three were moderate. In contrast , three of the nine headaches usi ng metrizam ide were mild and six were moderate , requiring medication. The mildness of th e reaction s with iopamidol has been previously reported [10] .
In addition to th e lesser severity of th e headaches thi s study also fo und an absence of neuropsychiatri c problem s with iopamidol. None of the pati ents studi ed with iopamidol was found to have th ese react ions, while six of the pati ents give n metrizamid e had one or more of th ese side effects. Oth er stu d ies have doc umented the lack of neuropsyc hi atri c fin d in gs when iopami dol was used [8, 11] . Thi s stud y also foun d a ve ry low freq uency of pain and nausea assoc iated with iopami dol. Pain was experien c ed by three patients give n metrizami de and no pati ents rece ivin g iopami dol. Ten of th e 18 pati ents receivi ng metrizamide experienced nausea , wh ile onl y one of 28 iopamidol cases had this side effect. Metriza mi de also accounted fo r th e two cases of retention of uri ne .
lopami dol images we re judged exce ll ent in 22 of 25 ca ses, as again st 11 of 18 for metriza mi de. lopamidol gave better contrast density discri min ation as we ll as eq ual or better visuali zation of nerve roots and sleeves when compared w ith metri zami de. It shou ld also be noted that iopamidol is stabl e in solu tion and does not need to be reconstituted . Ou r find in gs suggest th at iopami dol produces better quality myelog raphi c stu d ies than metrizam ide, and th at adve rse reactions to iopam idol are fewer and mil der than those associated w ith th e use of metri zamide.
